CRYOPORT, INC. Convertible Preferred Stock Converted to Other Securities
CRYOPORT, INC. (CYRX) reported Convertible Preferred Stock Converted to Other Securities of $101.80 million for the 9-month period ending 2014-12-31, per its 10-Q filed 2015-02-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities · last filed 2015-02-05
- CRYOPORT, INC. convertible preferred stock converted to other securities for the quarter ending 2014-12-31 was $14.60M.
- CRYOPORT, INC. convertible preferred stock converted to other securities for the quarter ending 2014-09-30 was $79.69M.
- CRYOPORT, INC. convertible preferred stock converted to other securities for the quarter ending 2014-06-30 was $7.51M.
| Period end | Convertible Preferred Stock Converted to Other Securities 3 month | Convertible Preferred Stock Converted to Other Securities 6 month | Convertible Preferred Stock Converted to Other Securities 9 month |
|---|---|---|---|
| 2014-12-31 | $14.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05 | $94.29M derived: sum of 2 quarters · filed 2015-02-05 | $101.80M 10-Q · filed 2015-02-05 |
| 2014-09-30 | $79.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-12 | $87.20M 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $7.51M 10-Q · filed 2014-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |